At Novonesis, we are leveraging recent advances in artificial intelligence and machine learning to drive scientific decision making across product development. From AI driven enzyme discovery and metagenomic mining to ML powered expression optimization and automated data interpretation, our teams deploy models that accelerate insight generation, streamline decisions, and open innovative routes that were previously inaccessible or too complex.

At SEPAWA, we will showcase how curated and structured data enables Novonesis to train, deploy, and operationalize AI/ML solutions across industries. Through examples—ranging from predictive models guiding sequence selection to AI supported design strategies—we demonstrate how data driven approaches increase the probability of success in product development.
By the end of the presentation, we will illustrate how strong domain expertise combined with modern AI capabilities delivers faster discovery, smarter experimentation, and a more connected R&D pipeline. Join us to explore how Novonesis is transforming biosolutions innovation through data driven science.